Team
World-class expertise in membrane-protein drug discovery.
Many decades of GPCR biology, multiple drug approvals, and direct operational experience leading discovery and BD.
Executive team
- MMMauro Mileni, PhDChief Executive Officer & Founder
- AKAnke Kretz-Rommel, PhDChief Scientific Officer
- CRChristopher Roth, PhDSenior Vice President of Research
- MRMatthew Ritter, PhDChief Business Officer
- SFScott Forrest, PhDBusiness & Finance Advisor
- JSJames SchmidtChief Financial Officer
Advisors
- Rakesh Dixit, PhDADC Discovery & Development
- Tracy Handel, PhDPharmacology, GPCRs
- Cath Hutchings, PhDTarget selection; mAb discovery
- Fred Ramsdell, PhD, Nobel LaureateOncology
- Scott Struthers, PhDExecutive
- Napoleone Ferrara, MDOncology
Board of Directors
- Dan BradburyFormer Amylin CEO
- Mike GoguenTwo Bear Capital
- Mauro Mileni, PhDAbilita Therapeutics CEO